Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques.

Rosenwirth, B

Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques. [electronic resource] - Vaccine Feb 2001 - 1661-70 p. digital

Publication Type: Journal Article

0264-410X

10.1016/s0264-410x(00)00416-3 doi


Animals
Antibodies--immunology
Autoimmunity--immunology
Avipoxvirus--genetics
Body Temperature
Body Weight
Enzyme-Linked Immunosorbent Assay
Female
Humans
Hypersensitivity, Delayed--immunology
Inflammation--chemically induced
Injections, Intravenous
Liver--drug effects
Lung--drug effects
Macaca mulatta--immunology
Male
Skin--drug effects
Spleen--drug effects
T-Lymphocytes, Cytotoxic--immunology
Tumor Suppressor Protein p53--administration & dosage
Vaccines, Synthetic--administration & dosage